Open Access
Issue
Vet. Res.
Volume 37, Number 3, May-June 2006
Mucosal immunology in domestic animals
Page(s) 487 - 510
DOI http://dx.doi.org/10.1051/vetres:2006012
Published online 14 April 2006
How to cite this article Vet. Res. (2006) 487-510
References of Vet. Res. 37 (2006) 487-510
  1. Abusugra I., Morein B., Iscom is an efficient mucosal delivery system for Mycoplasma mycoides subsp. mycoides (MmmSC) antigens inducing high mucosal and systemic antibody responses, FEMS Immunol. Med. Microbiol. 23 (1999) 5-12 [PubMed].
  2. Adam M., Lepottier M.F., Eloit M., Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies, Vet. Microbiol. 42 (1994) 205-215 [CrossRef] [PubMed].
  3. Allaoui-Attarki K., Pecquet S., Fattal E., Trolle S., Chachaty E., Couvreur P., Andremont A., Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres, Infect. Immun. 65 (1997) 853-857 [PubMed].
  4. Autenrieth I.B., Schmidt M.A., Bacterial interplay at intestinal mucosal surfaces: implications for vaccine development, Trends Microbiol. 8 (2000) 457-464 [CrossRef] [PubMed].
  5. Baca-Estrada M.E., Liang X., Babiuk L.A., Yoo D., Induction of mucosal immunity in cotton rats to haemagglutinin-esterase glycoprotein of bovine coronavirus by recombinant adenovirus, Immunology 86 (1995) 134-140 [PubMed].
  6. Baca-Estrada M.E., Foldvari M., Snider M., Induction of mucosal immune responses by administration of liposome-antigen formulations and interleukin-12, J. Interferon Cytokine Res. 19 (1999) 455-462 [PubMed].
  7. Baca-Estrada M.E., Foldvari M.M., Snider M.M., Harding K.K., Kournikakis B.B., Babiuk L.A., Griebel P.P., Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses, Vaccine 18 (2000) 2203-2211 [CrossRef] [PubMed].
  8. Balasuriya U.B., Heidner H.W., Davis N.L., Wagner H.M., Hullinger P.J., Hedges J.F., Williams J.C., Johnston R.E., David Wilson W., Liu I.K., James MacLachlan N., Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses, Vaccine 20 (2002) 1609-1617 [CrossRef] [PubMed].
  9. Baras B., Benoit M.A., Dupre L., Poulain-Godefroy O., Schacht A.M., Capron A., Gillard J., Riveau G., Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen, Infect. Immun. 67 (1999) 2643-2648 [PubMed].
  10. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., Osorio F.A., Construction and immunogenicity of recombinant Mycobacterium bovis BCG expressing GP5 and M protein of porcine reproductive respiratory syndrome virus, Vaccine 21 (2002) 21-29 [CrossRef] [PubMed].
  11. Bastos R.G., Dellagostin O.A., Barletta R.G., Doster A.R., Nelson E., Zuckermann F., Osorio F.A., Immune response of pigs inoculated with Mycobacterium bovis BCG expressing a truncated form of GP5 and M protein of porcine reproductive and respiratory syndrome virus, Vaccine 22 (2004) 467-474 [CrossRef] [PubMed].
  12. Baxi M.K., Deregt D., Robertson J., Babiuk L.A., Schlapp T., Tikoo S.K., Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats, Virology 278 (2000) 234-243 [CrossRef] [PubMed].
  13. Beier R., Gebert A., Kinetics of particle uptake in the domes of Peyer's patches, Am. J. Physiol. 275 (1998) G130-G137 [PubMed].
  14. Belyakov I.M., Hammond S.A., Ahlers J.D., Glenn G.M., Berzofsky J.A., Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells, J. Clin. Invest. 113 (2004) 998-1007 [CrossRef] [PubMed].
  15. Bjarnarson S.P., Jakobsen H., Del Giudice G., Trannoy E., Siegrist C.A., Jonsdottir I., The advantage of mucosal immunization for polysaccharide-specific memory responses in early life, Eur. J. Immunol. 35 (2005) 1037-1045 [PubMed].
  16. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., Brimnes M.K., Moltedo B., Moran T.M., Steinman R.M., In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination, J. Exp. Med. 199 (2004) 815-824 [CrossRef] [PubMed].
  17. Bowersock T.L., HogenEsch H., Torregrosa S., Borie D., Wang B., Park H., Park K., Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres, Immunol. Lett. 60 (1998) 37-43 [CrossRef] [PubMed].
  18. Bowersock T.L., HogenEsch H., Suckow M., Guimond P., Martin S., Borie D., Torregrosa S., Park H., Park K., Oral vaccination of animals with antigens encapsulated in alginate microspheres, Vaccine 17 (1999) 1804-1811 [CrossRef] [PubMed].
  19. Bowman E.P., Kuklin N.A., Youngman K.R., Lazarus N.H., Kunkel E.J., Pan J., Greenberg H.B., Butcher E.C., The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells, J. Exp. Med. 195 (2002) 269-275 [CrossRef] [PubMed].
  20. Boyle D.B., Selleck P., Heine H.G., Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin, Aust. Vet. J. 78 (2000) 44-48 [PubMed].
  21. Breathnach C.C., Rudersdorf R., Lunn D.P., Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination, Vet. Immunol. Immunopathol. 98 (2004) 127-136 [PubMed].
  22. Butter C., Sturman T.D., Baaten B.J., Davison T.F., Protection from infectious bursal disease virus (IBDV)-induced immunosuppression by immunization with a fowlpox recombinant containing IBDV-VP2, Avian Pathol. 32 (2003) 597-604 [CrossRef] [PubMed].
  23. Callebaut P., Enjuanes L., Pensaert M., An adenovirus recombinant expressing the spike glycoprotein of porcine respiratory coronavirus is immunogenic in swine, J. Gen. Virol. 77 (1996) 309-313 [PubMed].
  24. Carcaboso A.M., Hernandez R.M., Igartua M., Rosas J.E., Patarroyo M.E., Pedraz J.L., Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles, Vaccine 22 (2004) 1423-1432 [CrossRef] [PubMed].
  25. Cardona C.J., Reed W.M., Witter R.L., Silva R.F., Protection of turkeys from hemorrhagic enteritis with a recombinant fowl poxvirus expressing the native hexon of hemorrhagic enteritis virus, Avian Dis. 43 (1999) 234-244 [CrossRef] [PubMed].
  26. Carol H., Nieto A., A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms, Vet. Immunol. Immunopathol. 65 (1998) 29-41 [PubMed].
  27. Chen H., Torchilin V., Langer R., Lectin-bearing polymerized liposomes as potential oral vaccine carriers, Pharm. Res. 13 (1996) 1378-1383 [CrossRef] [PubMed].
  28. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C., Greenberg H.B., Herrmann J.E., Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles, J. Virol. 72 (1998) 5757-5761 [PubMed].
  29. Clark M.A., Hirst B.H., Jepson M.A., M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells, Infect. Immun. 66 (1998) 1237-1243 [PubMed].
  30. Colonna M., Trinchieri G., Liu Y.J., Plasmacytoid dendritic cells in immunity, Nat. Immunol. 5 (2004) 1219-1226 [CrossRef] [PubMed].
  31. Cox E., Van der Stede Y., Verdonck F., Snoeck V., Van den Broeck W., Goddeeris B., Oral immunisation of pigs with fimbrial antigens of enterotoxigenic E. coli: an interesting model to study mucosal immune mechanisms, Vet. Immunol. Immunopathol. 87 (2002) 287-290 [PubMed].
  32. Cox E., Verdonck F., Goddeeris B., Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa, Vet. Res. (2006) 511-539.
  33. Darji A., Guzman C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., Chakraborty T., Weiss S., Oral somatic transgene vaccination using attenuated S. typhimurium, Cell 91 (1997) 765-775 [CrossRef] [PubMed].
  34. Darji A., zur Lage S., Garbe A.I., Chakraborty T., Weiss S., Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier, FEMS Immunol. Med. Microbiol. 27 (2000) 341-349 [PubMed].
  35. Darteil R., Bublot M., Laplace E., Bouquet J.F., Audonnet J.C., Riviere M., Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens, Virology 211 (1995) 481-490 [CrossRef] [PubMed].
  36. Diallo A., Minet C., Berhe G., Le Goff C., Black D.N., Fleming M., Barrett T., Grillet C., Libeau G., Goat immune response to capripox vaccine expressing the hemagglutinin protein of peste des petits ruminants, Ann. NY Acad. Sci. 969 (2002) 88-91.
  37. Dietrich G., Spreng S., Favre D., Viret J.F., Guzman C.A., Live attenuated bacteria as vectors to deliver plasmid DNA vaccines, Curr. Opin. Mol. Ther. 5 (2003) 10-19 [PubMed].
  38. Dieye Y., Hoekman A.J., Clier F., Juillard V., Boot H.J., Piard J.C., Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines, Appl. Environ. Microbiol. 69 (2003) 7281-7288 [CrossRef] [PubMed].
  39. Dougan G., Hormaeche C.E., Maskell D.J., Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system, Parasite Immunol. 9 (1987) 151-160 [PubMed].
  40. Ebensen T., Paukner S., Link C., Kudela P., de Domenico C., Lubitz W., Guzman C.A., Bacterial ghosts are an efficient delivery system for DNA vaccines, J. Immunol. 172 (2004) 6858-6865 [PubMed].
  41. Elahi S.M., Shen S.H., Talbot B.G., Massie B., Harpin S., Elazhary Y., Induction of humoral and cellular immune responses against the nucleocapsid of bovine viral diarrhea virus by an adenovirus vector with an inducible promoter, Virology 261 (1999) 1-7 [CrossRef] [PubMed].
  42. Elahi S.M., Shen S.H., Talbot B.G., Massie B., Harpin S., Elazhary Y., Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses, FEMS Microbiol. Lett. 177 (1999) 159-166 [PubMed].
  43. Eloit M., Gilardi-Hebenstreit P., Toma B., Perricaudet M., Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine, J. Gen. Virol. 71 (1990) 2425-2431 [PubMed].
  44. Enouf V., Langella P., Commissaire J., Cohen J., Corthier G., Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic, Appl. Environ. Microbiol. 67 (2001) 1423-1428 [CrossRef] [PubMed].
  45. Fattal E., Pecquet S., Couvreur P., Andremont A., Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens, Int. J. Pharm. 242 (2002) 15-24 [CrossRef] [PubMed].
  46. Felder C.B., Vorlaender N., Gander B., Merkle H.P., Bertschinger H.U., Microencapsulated enterotoxigenic Escherichia coli and detached fimbriae for peroral vaccination of pigs, Vaccine 19 (2000) 706-715 [CrossRef] [PubMed].
  47. Fischer L., Tronel J.P., Pardo-David C., Tanner P., Colombet G., Minke J., Audonnet J.C., Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge, Vaccine 20 (2002) 3485-3497 [CrossRef] [PubMed].
  48. Foster N., Clark M.A., Jepson M.A., Hirst B.H., Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo, Vaccine 16 (1998) 536-541 [CrossRef] [PubMed].
  49. Francois A., Chevalier C., Delmas B., Eterradossi N., Toquin D., Rivallan G., Langlois P., Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens, Vaccine 22 (2004) 2351-2360 [CrossRef] [PubMed].
  50. Fukutome K., Watarai S., Mukamoto M., Kodama H., Intestinal mucosal immune response in chickens following intraocular immunization with liposome-associated Salmonella enterica serovar enteritidis antigen, Dev. Comp. Immunol. 25 (2001) 475-484 [PubMed].
  51. Furrie E., Smith R.E., Turner M.W., Strobel S., Mowat A.M., Induction of local innate immune responses and modulation of antigen uptake as mechanisms underlying the mucosal adjuvant properties of immune stimulating complexes (ISCOMS), Vaccine 20 (2002) 2254-2262 [CrossRef] [PubMed].
  52. Gagnon C.A., Lachapelle G., Langelier Y., Massie B., Dea S., Adenoviral-expressed GP5 of porcine respiratory and reproductive syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions, Arch. Virol. 148 (2003) 951-972 [CrossRef] [PubMed].
  53. Garmory H.S., Leary S.E., Griffin K.F., Williamson E.D., Brown K.A., Titball R.W., The use of live attenuated bacteria as a delivery system for heterologous antigens, J. Drug Target. 11 (2003) 471-479 [CrossRef] [PubMed].
  54. Gasque P., Complement: a unique innate immune sensor for danger signals, Mol. Immunol. 41 (2004) 1089-1098 [CrossRef] [PubMed].
  55. Gentschev I., Mollenkopf H., Sokolovic Z., Hess J., Kaufmann S.H., Goebel W., Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway, Gene 179 (1996) 133-140 [CrossRef] [PubMed].
  56. Gentschev I., Glaser I., Goebel W., McKeever D.J., Musoke A., Heussler V.T., Delivery of the p67 sporozoite antigen of Theileria parva by using recombinant Salmonella dublin: secretion of the product enhances specific antibody responses in cattle, Infect. Immun. 66 (1998) 2060-2064 [PubMed].
  57. Gentschev I., Dietrich G., Goebel W., The E. coli alpha-hemolysin secretion system and its use in vaccine development, Trends Microbiol. 10 (2002) 39-45 [CrossRef] [PubMed].
  58. Giannasca P.J., Boden J.A., Monath T.P., Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins, Infect. Immun. 65 (1997) 4288-4298 [PubMed].
  59. Gogev S., Vanderheijden N., Lemaire M., Schynts F., D'Offay J., Deprez I., Adam M., Eloit M., Thiry E., Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD, Vaccine 20 (2002) 1451-1465 [CrossRef] [PubMed].
  60. Gonin P., Fournier A., Oualikene W., Moraillon A., Eloit M., Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus, Vet. Microbiol. 45 (1995) 393-401 [CrossRef] [PubMed].
  61. Gregoriadis G., Immunological adjuvants: a role for liposomes, Immunol. Today 11 (1990) 89-97 [CrossRef] [PubMed].
  62. Hammond J.M., McCoy R.J., Jansen E.S., Morrissy C.J., Hodgson A.L., Johnson M.A., Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever, Vaccine 18 (2000) 1040-1050 [CrossRef] [PubMed].
  63. Hammond J.M., Jansen E.S., Morrissy C.J., van der Heide B., Goff W.V., Williamson M.M., Hooper P.T., Babiuk L.A., Tikoo S.K., Johnson M.A., Vaccination of pigs with a recombinant porcine adenovirus expressing the gD gene from pseudorabies virus, Vaccine 19 (2001) 3752-3758 [CrossRef] [PubMed].
  64. Harokopakis E., Hajishengallis G., Michalek S.M., Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system, Infect. Immun. 66 (1998) 4299-4304 [PubMed].
  65. Hebben M., Duquesne V., Cronier J., Rossi B., Aubert A., Modified vaccinia virus Ankara as a vaccine against feline coronavirus: immunogenicity and efficacy, J. Feline Med. Surg. 6 (2004) 111-118 [CrossRef] [PubMed].
  66. Heine H.G., Boyle D.B., Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens, Arch. Virol. 131 (1993) 277-292 [CrossRef] [PubMed].
  67. Herrmann J.E., Chen S.C., Jones D.H., Tinsley-Bown A., Fynan E.F., Greenberg H.B., Farrar G.H., Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles, Virology 259 (1999) 148-153 [CrossRef] [PubMed].
  68. Hoebe K., Janssen E., Beutler B., The interface between innate and adaptive immunity, Nat. Immunol. 5 (2004) 971-974 [CrossRef] [PubMed].
  69. Holmgren J., Czerkinsky C., Mucosal immunity and vaccines, Nat. Med. 11 (2005) S45-S53 [CrossRef] [PubMed].
  70. Hu K.F., Elvander M., Merza M., Akerblom L., Brandenburg A., Morein B., The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses, Clin. Exp. Immunol. 113 (1998) 235-243 [PubMed].
  71. Huang Z., Elankumaran S., Yunus A.S., Samal S.K., A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV, J. Virol. 78 (2004) 10054-10063 [CrossRef] [PubMed].
  72. Hussain N., Florence A.T., Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles, Pharm. Res. 15 (1998) 153-156 [CrossRef] [PubMed].
  73. Jepson M.A., Clark M.A., Foster N., Mason C.M., Bennett M.K., Simmons N.L., Hirst B.H., Targeting to intestinal M cells, J. Anat. 189 (1996) 507-516 [PubMed].
  74. Johansson-Lindbom B., Svensson M., Wurbel M.A., Malissen B., Marquez G., Agace W., Selective generation of gut tropic T cells in gut-associated lymphoid tissue (GALT): requirement for GALT dendritic cells and adjuvant, J. Exp. Med. 198 (2003) 963-969 [CrossRef] [PubMed].
  75. Johnson M.A., Pooley C., Ignjatovic J., Tyack S.G., A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus, Vaccine 21 (2003) 2730-2736 [CrossRef] [PubMed].
  76. Jones D.H., McBride B.W., Thornton C., O'Hagan D.T., Robinson A., Farrar G.H., Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection, Infect. Immun. 64 (1996) 489-494 [PubMed].
  77. Joseph A., Louria-Hayon I., Plis-Finarov A., Zeira E., Zakay-Rones Z., Raz E., Hayashi T., Takabayashi K., Barenholz Y., Kedar E., Liposomal immunostimulatory DNA sequence (ISS-ODN): an efficient parenteral and mucosal adjuvant for influenza and hepatitis B vaccines, Vaccine 20 (2002) 3342-3354 [CrossRef] [PubMed].
  78. Kelsall B.L., Rescigno M., Mucosal dendritic cells in immunity and inflammation, Nat. Immunol. 5 (2004) 1091-1095 [CrossRef] [PubMed].
  79. Kesik M., Saczynska V., Szewczyk B., Plucienniczak A., Inclusion bodies from recombinant bacteria as a novel system for delivery of vaccine antigen by the oral route, Immunol. Lett. 91 (2004) 197-204 [CrossRef] [PubMed].
  80. Kidane A., Guimond P., Ju T.R., Sanchez M., Gibson J., Bowersock T.L., The efficacy of oral vaccination of mice with alginate encapsulated outer membrane proteins of Pasteurella haemolytica and One-Shot, Vaccine 19 (2001) 2637-2646 [CrossRef] [PubMed].
  81. Kim B., Bowersock T., Griebel P., Kidane A., Babiuk L.A., Sanchez M., Attah-Poku S., Kaushik R.S., Mutwiri G.K., Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres, J. Control. Release 85 (2002) 191-202 [CrossRef] [PubMed].
  82. Kit M., Kit S., Little S.P., Di Marchi R.D., Gale C., Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes, Vaccine 9 (1991) 564-572 [CrossRef] [PubMed].
  83. Kit S., Kit M., DiMarchi R.D., Little S.P., Gale C., Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles, Arch. Virol. 120 (1991) 1-17 [CrossRef] [PubMed].
  84. Kit S., Otsuka H., Kit M., Expression of porcine pseudorabies virus genes by a bovine herpesvirus-1 (infectious bovine rhinotracheitis virus) vector, Arch. Virol. 124 (1992) 1-20 [CrossRef] [PubMed].
  85. Kunkel E.J., Butcher E.C., Plasma-cell homing, Nat. Rev. Immunol. 3 (2003) 822-829 [CrossRef] [PubMed].
  86. Kweon C.H., Kang S.W., Choi E.J., Kang Y.B., Bovine herpes virus expressing envelope protein (E2) of bovine viral diarrhea virus as a vaccine candidate, J. Vet. Med. Sci. 61 (1999) 395-401 [CrossRef] [PubMed].
  87. Lazarus N.H., Kunkel E.J., Johnston B., Wilson E., Youngman K.R., Butcher E.C., A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts, J. Immunol. 170 (2003) 3799-3805 [PubMed].
  88. Lee J.S., Hadjipanayis A.G., Welkos S.L., Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge, Infect. Immun. 71 (2003) 1491-1496 [CrossRef] [PubMed].
  89. Liao C.W., Chiou H.Y., Yeh K.S., Chen J.R., Weng C.N., Oral immunization using formalin-inactivated Actinobacillus pleuropneumoniae antigens entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process, Prev. Vet. Med. 61 (2003) 1-15 [CrossRef] [PubMed].
  90. Lin J.H., Weng C.N., Liao C.W., Yeh K.S., Pan M.J., Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method, J. Vet. Med. Sci. 65 (2003) 69-74 [CrossRef] [PubMed].
  91. Liu W., Yang Y., Chung N., Kwang J., Induction of humoral immune response and protective immunity in chickens against Salmonella enteritidis after a single dose of killed bacterium-loaded microspheres, Avian Dis. 45 (2001) 797-806 [CrossRef] [PubMed].
  92. Liu Y.-J., IPC: Professional type i interferon-producing cells and plasmacytoid dendritic cell precursors, Ann. Rev. Immunol. 23 (2005) 275-306.
  93. Locht C., Live bacterial vectors for intranasal delivery of protective antigens, Pharm. Sci. Technol. Today 3 (2000) 121-128 [PubMed].
  94. Loessner H., Weiss S., Bacteria-mediated DNA transfer in gene therapy and vaccination, Exp. Opin. Biol. Ther. 4 (2004) 157-168.
  95. Lovgren K., Kaberg H., Morein B., An experimental influenza subunit vaccine (ISCOM): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration, Clin. Exp. Immunol. 82 (1990) 435-439 [PubMed].
  96. MacPherson G., Milling S., Yrlid U., Cousins L., Turnbull E., Huang F.P., Uptake of antigens from the intestine by dendritic cells, Ann. NY Acad. Sci. 1029 (2004) 75-82.
  97. Maloy K.J., Donachie A.M., Mowat A.M., Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS, Eur. J. Immunol. 25 (1995) 2835-2841 [PubMed].
  98. McGreal E.P., Martinez-Pomares L., Gordon S., Divergent roles for C-type lectins expressed by cells of the innate immune system, Mol. Immunol. 41 (2004) 1109-1121 [CrossRef] [PubMed].
  99. McKenna K., Beignon A.S., Bhardwaj N., Plasmacytoid dendritic cells: linking innate and adaptive immunity, J. Virol. 79 (2005) 17-27 [CrossRef] [PubMed].
  100. McKenzie B.S., Corbett A.J., Johnson S., Brady J.L., Pleasance J., Kramer D.R., Boyle J.S., Jackson D.C., Strugnell R.A., Lew A.M., Bypassing luminal barriers, delivery to a gut addressin by parenteral targeting elicits local IgA responses, Int. Immunol. 16 (2004) 1613-1622 [CrossRef] [PubMed].
  101. Medina E., Guzman C.A., Use of live bacterial vaccine vectors for antigen delivery: potential and limitations, Vaccine 19 (2001) 1573-1580 [CrossRef] [PubMed].
  102. Men Y., Audran R., Thomasin C., Eberl G., Demotz S., Merkle H.P., Gander B., Corradin G., MHC class I- and class II-restricted processing and presentation of microencapsulated antigens, Vaccine 17 (1999) 1047-1056 [CrossRef] [PubMed].
  103. Meurens F., Keil G.M., Muylkens B., Gogev S., Schynts F., Negro S., Wiggers L., Thiry E., Interspecific recombination between two ruminant alphaherpesviruses, bovine herpesviruses 1 and 5, J. Virol. 78 (2004) 9828-9836 [CrossRef] [PubMed].
  104. Michalek S., O'Hagan D., Gould-Fogerite S., Rimmelzwaan G., Osterhaus A., Antigen delivery systems: Non-living microparticles, liposomes, cochleates and ISCOMs, Academic Press, San Diego, 1999, pp. 759-778.
  105. Minke J.M., Siger L., Karaca K., Austgen L., Gordy P., Bowen R., Renshaw R.W., Loosmore S., Audonnet J.C., Nordgren B., Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge, Arch. Virol. Suppl. (2004) 221-230.
  106. Mishima M., Xuan X., Yokoyama N., Igarashi I., Fujisaki K., Nagasawa H., Mikami T., Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats, Parasitol. Res. 88 (2002) 144-149 [CrossRef] [PubMed].
  107. Moore R.J., Rothel L., Krywult J., Radford A.J., Lund K., Hodgson A.L., Foreign gene expression in Corynebacterium pseudotuberculosis: development of a live vaccine vector, Vaccine 18 (1999) 487-497 [CrossRef] [PubMed].
  108. Moore R.J., Stewart D.J., Lund K., Hodgson A.L., Vaccination against ovine footrot using a live bacterial vector to deliver basic protease antigen, FEMS Microbiol. Lett. 194 (2001) 193-196 [PubMed].
  109. Mora J.R., Bono M.R., Manjunath N., Weninger W., Cavanagh L.L., Rosemblatt M., Von Andrian U.H., Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells, Nature 424 (2003) 88-93 [CrossRef] [PubMed].
  110. Morein B., Villacres-Eriksson M., Lovgren-Bengtsson K., Iscom, a delivery system for parenteral and mucosal vaccination, Dev. Biol. Stand. 92 (1998) 33-39 [PubMed].
  111. Morein B., Hu K.F., Abusugra I., Current status and potential application of ISCOMs in veterinary medicine, Adv. Drug Deliv. Rev. 56 (2004) 1367-1382 [CrossRef] [PubMed].
  112. Morris-Downes M.M., Sheahan B.J., Fleeton M.N., Liljestrom P., Reid H.W., Atkins G.J., A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model, Vaccine 19 (2001) 3877-3884 [CrossRef] [PubMed].
  113. Mowat A.M., Smith R.E., Donachie A.M., Furrie E., Grdic D., Lycke N., Oral vaccination with immune stimulating complexes, Immunol. Lett. 65 (1999) 133-140 [CrossRef] [PubMed].
  114. Murillo M., Grillo M.J., Rene J., Marin C.M., Barberan M., Goni M.M., Blasco J.M., Irache J.M., Gamazo C., A Brucella ovis antigenic complex bearing poly-epsilon-caprolactone microparticles confer protection against experimental brucellosis in mice, Vaccine 19 (2001) 4099-4106 [CrossRef] [PubMed].
  115. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., Littman D.R., Reinecker H.C., CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance, Science 307 (2005) 254-258 [CrossRef].
  116. O'Hagan D.T., The intestinal uptake of particles and the implications for drug and antigen delivery, J. Anat. 189 (1996) 477-482 [PubMed].
  117. O'Hagan D.T., Microparticles and polymers for the mucosal delivery of vaccines, Adv. Drug Deliv. Rev. 34 (1998) 305-320 [CrossRef] [PubMed].
  118. Orr N., Galen J.E., Levine M.M., Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhimurium vaccine strain CVD 908-htrA, Infect. Immun. 67 (1999) 4290-4294 [PubMed].
  119. Pabst O., Ohl L., Wendland M., Wurbel M.A., Kremmer E., Malissen B., Forster R., Chemokine receptor CCR9 contributes to the localization of plasma cells to the small intestine, J. Exp. Med. 199 (2004) 411-416 [CrossRef] [PubMed].
  120. Papadakis K.A., Prehn J., Nelson V., Cheng L., Binder S.W., Ponath P.D., Andrew D.P., Targan S.R., The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system, J. Immunol. 165 (2000) 5069-5076 [PubMed].
  121. Pardo M.C., Bauman J.E., Mackowiak M., Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins, Am. J. Vet. Res. 58 (1997) 833-836 [PubMed].
  122. Payne L.G., Andrianov A.K., Protein release from polyphosphazene matrices, Adv. Drug Deliv. Rev. 31 (1998) 185-196 [CrossRef] [PubMed].
  123. Payne L.G., Jenkins S.A., Andrianov A., Roberts B.E., Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery, Pharm. Biotechnol. 6 (1995) 473-493 [PubMed].
  124. Phenix K.V., Wark K., Luke C.J., Skinner M.A., Smyth J.A., Mawhinney K.A., Todd D., Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development, Vaccine 19 (2001) 3116-3123 [CrossRef] [PubMed].
  125. Pogonka T., Klotz C., Kovacs F., Lucius R., A single dose of recombinant Salmonella typhimurium induces specific humoral immune responses against heterologous Eimeria tenella antigens in chicken, Int. J. Parasitol. 33 (2003) 81-88 [CrossRef] [PubMed].
  126. Prevec L., Campbell J.B., Christie B.S., Belbeck L., Graham F.L., A recombinant human adenovirus vaccine against rabies, J. Infect. Dis. 161 (1990) 27-30 [PubMed].
  127. Raulet D.H., Interplay of natural killer cells and their receptors with the adaptive immune response, Nat. Immunol. 5 (2004) 996-1002 [CrossRef] [PubMed].
  128. Rebelatto M.C., Guimond P., Bowersock T.L., HogenEsch H., Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles, Vet. Immunol. Immunopathol. 83 (2001) 93-105 [PubMed].
  129. Reddy P.S., Idamakanti N., Pyne C., Zakhartchouk A.N., Godson D.L., Papp Z., Baca-Estrada M.E., Babiuk L.A., Mutwiri G.K., Tikoo S.K., The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle, Vet. Immunol. Immunopathol. 76 (2000) 257-268 [PubMed].
  130. Reddy S.K., Sharma J.M., Ahmad J., Reddy D.N., McMillen J.K., Cook S.M., Wild M.A., Schwartz R.D., Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens, Vaccine 14 (1996) 469-477 [CrossRef] [PubMed].
  131. Rescigno M., Identification of a new mechanism for bacterial uptake at mucosal surfaces, which is mediated by dendritic cells, Pathol. Biol. 51 (2003) 69-70 [CrossRef] [PubMed].
  132. Rescigno M., Chieppa M., Gut-level decisions in peace and war, Nat. Med. 11 (2005) 254-255 [CrossRef] [PubMed].
  133. Roland K.L., Tinge S.A., Killeen K.P., Kochi S.K., Recent advances in the development of live, attenuated bacterial vectors, Curr. Opin. Mol. Ther. 7 (2005) 62-72 [PubMed].
  134. Roque-Resendiz J.L., Rosales R., Herion P., MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis, Parasitology 128 (2004) 397-405 [CrossRef] [PubMed].
  135. Rothel J.S., Boyle D.B., Both G.W., Pye A.D., Waterkeyn J.G., Wood P.R., Lightowlers M.W., Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep, Parasite Immunol. 19 (1997) 221-227 [PubMed].
  136. Roth-Walter F., Scholl I., Untersmayr E., Fuchs R., Boltz-Nitulescu G., Weissenbock A., Scheiner O., Gabor F., Jensen-Jarolim E., M cell targeting with Aleuria aurantia lectin as a novel approach for oral allergen immunotherapy, J. Allergy Clin. Immunol. 114 (2004) 1362-1368 [CrossRef] [PubMed].
  137. Roth-Walter F., Scholl I., Untersmayr E., Ellinger A., Boltz-Nitulescu G., Scheiner O., Gabor F., Jensen-Jarolim E., Mucosal targeting of allergen-loaded microspheres by Aleuria aurantia lectin, Vaccine 23 (2005) 2703-2710 [CrossRef] [PubMed].
  138. Schrijver R.S., Langedijk J.P., Keil G.M., Middel W.G., Maris-Veldhuis M., Van Oirschot J.T., Rijsewijk F.A., Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV, Vaccine 15 (1997) 1908-1916 [CrossRef] [PubMed].
  139. Schwantes A., Truyen U., Weikel J., Weiss C., Lochelt M., Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats, J. Virol. 77 (2003) 7830-7842 [CrossRef] [PubMed].
  140. Sheppard M., Viral vectors for veterinary vaccines, Adv. Vet. Med. 41 (1999) 145-161 [PubMed].
  141. Sheppard M., Werner W., Tsatas E., McCoy R., Prowse S., Johnson M., Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease, Arch. Virol. 143 (1998) 915-930 [CrossRef] [PubMed].
  142. Shiau A.L., Chen Y.L., Liao C.Y., Huang Y.S., Wu C.L., Prothymosin alpha enhances protective immune responses induced by oral DNA vaccination against pseudorabies delivered by Salmonella choleraesuis, Vaccine 19 (2001) 3947-3956 [CrossRef] [PubMed].
  143. Shiau A.L., Chu C.Y., Su W.C., Wu C.L., Vaccination with the glycoprotein D gene of pseudorabies virus delivered by nonpathogenic Escherichia coli elicits protective immune responses, Vaccine 19 (2001) 3277-3284 [CrossRef] [PubMed].
  144. Shimoji Y., Oishi E., Kitajima T., Muneta Y., Shimizu S., Mori Y., Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs, Infect. Immun. 70 (2002) 226-232 [CrossRef] [PubMed].
  145. Singh M., Vajdy M., Gardner J., Briones M., O'Hagan D., Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity, Vaccine 20 (2001) 594-602 [CrossRef] [PubMed].
  146. Sirard J.C., Weber M., Duflot E., Popoff M.R., Mock M., A recombinant Bacillus anthracis strain producing the Clostridium perfringens Ib component induces protection against iota toxins, Infect. Immun. 65 (1997) 2029-2033 [PubMed].
  147. Sizemore D.R., Branstrom A.A., Sadoff J.C., Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization, Science 270 (1995) 299-302 [CrossRef].
  148. Sizemore D.R., Branstrom A.A., Sadoff J.C., Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization, Vaccine 15 (1997) 804-807 [CrossRef] [PubMed].
  149. Smith R.E., Donachie A.M., Grdic D., Lycke N., Mowat A.M., Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses, J. Immunol. 162 (1999) 5536-5546 [PubMed].
  150. Snoeck V., Huyghebaert N., Cox E., Vermeire A., Vancaeneghem S., Remon J.P., Goddeeris B.M., Enteric-coated pellets of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections, Vet. Immunol. Immunopathol. 96 (2003) 219-227 [PubMed].
  151. Stocker B.A., Aromatic-dependent salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them, J. Biotechnol. 83 (2000) 45-50 [CrossRef] [PubMed].
  152. Su G.F., Brahmbhatt H.N., de Lorenzo V., Wehland J., Timmis K.N., Extracellular export of Shiga toxin B-subunit/haemolysin A (C-terminus) fusion protein expressed in Salmonella typhimurium aroA-mutant and stimulation of B-subunit specific antibody responses in mice, Microb. Pathog. 13 (1992) 465-476 [PubMed].
  153. Supply P., Sutton P., Coughlan S.N., Bilo K., Saman E., Trees A.J., Cesbron Delauw M.F., Locht C., Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii, Vaccine 17 (1999) 705-714 [CrossRef] [PubMed].
  154. Tacket C.O., Reid R.H., Boedeker E.C., Losonsky G., Nataro J.P., Bhagat H., Edelman R., Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres, Vaccine 12 (1994) 1270-1274 [CrossRef] [PubMed].
  155. Tana Watarai S., Isogai E., Oguma K., Induction of intestinal IgA and IgG antibodies preventing adhesion of verotoxin-producing Escherichia coli to Caco-2 cells by oral immunization with liposomes, Lett. Appl. Microbiol. 36 (2003) 135-139 [PubMed].
  156. Taylor G., Rijsewijk F.A., Thomas L.H., Wyld S.G., Gaddum R.M., Cook R.S., Morrison W.I., Hensen E., van Oirschot J.T., Keil G., Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV, J. Gen. Virol. 79 (1998) 1759-1767 [PubMed].
  157. Thiry E., Meurens F., Muylkens B., McVoy M., Gogev S., Thiry J., Vanderplasschen A., Epstein A., Keil G., Schynts F., Recombination in alphaherpesviruses, Rev. Med. Virol. 15 (2005) 89-103 [PubMed].
  158. Thole J.E., van Dalen P.J., Havenith C.E., Pouwels P.H., Seegers J.F., Tielen F.D., van der Zee M.D., Zegers N.D., Shaw M., Live bacterial delivery systems for development of mucosal vaccines, Curr. Opin. Mol. Ther. 2 (2000) 94-99 [PubMed].
  159. Torche A.M., Jouan H., Le Corre P., Albina E., Primault R., Jestin A., Le Verge R., Ex vivo and in situ PLGA microspheres uptake by pig ileal Peyer's patch segment, Int. J. Pharm. 201 (2000) 15-27 [CrossRef] [PubMed].
  160. Torche A.M., Le Corre P., Albina E., Jestin A., Le Verge R., PLGA microspheres phagocytosis by pig alveolar macrophages: influence of poly(vinyl alcohol) concentration, nature of loaded-protein and copolymer nature, J. Drug Target. 7 (2000) 343-354 [PubMed].
  161. Torres J.M., Alonso C., Ortega A., Mittal S., Graham F., Enjuanes L., Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus, J. Virol. 70 (1996) 3770-3780 [PubMed].
  162. Tsukamoto K., Saito S., Saeki S., Sato T., Tanimura N., Isobe T., Mase M., Imada T., Yuasa N., Yamaguchi S., Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens, J. Virol. 76 (2002) 5637-5645 [CrossRef] [PubMed].
  163. Tuboly T., Nagy E., Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene, J. Gen. Virol. 82 (2001) 183-190 [PubMed].
  164. Tzschaschel B.D., Klee S.R., de Lorenzo V., Timmis K.N., Guzman C.A., Towards a vaccine candidate against Shigella dysenteriae, 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain, Microb. Pathog. 21 (1996) 277-288 [PubMed].
  165. Vajdy M., O'Hagan D.T., Microparticles for intranasal immunization, Adv. Drug Deliv. Rev. 51 (2001) 127-141 [CrossRef] [PubMed].
  166. Van der Leek M.L., Feller J.A., Sorensen G., Isaacson W., Adams C.L., Borde D.J., Pfeiffer N., Tran T., Moyer R.W., Gibbs E.P., Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63, Vet. Rec. 134 (1994) 13-18 [PubMed].
  167. Van Zijl M., Wensvoort G., de Kluyver E., Hulst M., van der Gulden H., Gielkens A., Berns A., Moormann R., Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera, J. Virol. 65 (1991) 2761-2765 [PubMed].
  168. Verdonck F., De Hauwere V., Bouckaert J., Goddeeris B.M., Cox E., Fimbriae of enterotoxigenic Escherichia coli function as a mucosal carrier for a coupled heterologous antigen, J. Control. Release 104 (2005) 243-258 [PubMed].
  169. Wang D., Christopher M.E., Nagata L.P., Zabielski M.A., Li H., Wong J.P., Samuel J., Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses, J. Clin. Virol. 31 Suppl. 1 (2004) S99-S106 [CrossRef] [PubMed].
  170. Wang X., Hone D.M., Haddad A., Shata M.T., Pascual D.W., M cell DNA vaccination for CTL immunity to HIV, J. Immunol. 171 (2003) 4717-4725 [PubMed].
  171. Welter J., Taylor J., Tartaglia J., Paoletti E., Stephensen C.B., Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines, J. Virol. 74 (2000) 6358-6367 [CrossRef] [PubMed].
  172. Wimsatt J., Biggins D., Innes K., Taylor B., Garell D., Evaluation of oral and subcutaneous delivery of an experimental canarypox recombinant canine distemper vaccine in the Siberian polecat (Mustela eversmanni), J. Zoo Wildl. Med. 34 (2003) 25-35 [PubMed].
  173. Wu Y., Wang X., Csencsits K.L., Haddad A., Walters N., Pascual D.W., M cell-targeted DNA vaccination, Proc. Natl. Acad. Sci. USA 98 (2001) 9318-9323 [CrossRef] [PubMed].
  174. Yarosh O.K., Wandeler A.I., Graham F.L., Campbell J.B., Prevec L., Human adenovirus type 5 vectors expressing rabies glycoprotein, Vaccine 14 (1996) 1257-1264 [CrossRef] [PubMed].
  175. Yokoyama N., Maeda K., Mikami T., Recombinant viral vector vaccines for the veterinary use, J. Vet. Med. Sci. 59 (1997) 311-322 [CrossRef] [PubMed].
  176. Yokoyama N., Fujita K., Damiani A., Sato E., Kurosawa K., Miyazawa T., Ishiguro S., Mochizuki M., Maeda K., Mikami T., Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen, J. Vet. Med. Sci. 60 (1998) 717-723 [CrossRef] [PubMed].
  177. Zakhartchouk A.N., Reddy P.S., Baxi M., Baca-Estrada M.E., Mehtali M., Babiuk L.A., Tikoo S.K., Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD, Virology 250 (1998) 220-229 [CrossRef] [PubMed].
  178. Zakhartchouk A.N., Pyne C., Mutwiri G.K., Papp Z., Baca-Estrada M.E., Griebel P., Babiuk L.A., Tikoo S.K., Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1, J. Gen. Virol. 80 (1999) 1263-1269 [PubMed].
  179. Zho F., Neutra M.R., Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier, Biosci. Rep. 22 (2002) 355-369 [CrossRef] [PubMed].
  180. Zhou F., Kraehenbuhl J.P., Neutra M.R., Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes, Vaccine 13 (1995) 637-644 [CrossRef] [PubMed].